Biomarkers for Clinical Benefit of Immune Checkpoint Inhibitor Treatment—A Review From the Melanoma Perspective and Beyond

Por Buder-Bakhaya, Kristina, Hassel, Jessica C.
Publicado no Front Immunol (2018)

Progression patterns under BRAF inhibitor treatment and treatment beyond progression in patients with metastatic melanoma

Por Hassel, Jessica C., Buder‐Bakhaya, Kristina, Bender, Carolin, Zimmer, Lisa, Weide, Benjamin, Loquai, Carmen, Ugurel, Selma, Slynko, Alla, Gutzmer, Ralf
Publicado no Cancer Med (2017)

Merkel cell carcinoma expresses the immunoregulatory ligand CD200 and induces immunosuppressive macrophages and regulatory T cells

Por Gaiser, Maria Rita, Weis, Cleo-Aron, Gaiser, Timo, Jiang, Hong, Buder-Bakhaya, Kristina, Herpel, Esther, Warth, Arne, Xiao, Ying, Miao, Lingling, Brownell, Isaac
Publicado no Oncoimmunology (2018)